COA 2013 :带线锚钉修复伸肌止点治疗顽固性网球肘的护理指导

2014-01-26 陈艳, 唐康来 第三军医大学西南医院 2013COA大会论文汇编

目的:探讨带线锚钉修复伸肌止点治疗顽固性网球肘相应护理指导的临床效果。方法:2009年3月至2011年5月接受单个代线锚钉修复桡侧腕短伸肌(ECRB)及指总伸肌腱止点治疗的顽固性肱骨外髁炎患者10例,共10肘,采用有效术前宣教和术后分阶段的综合护理指导。结果:本组10例患者术后切口均一期愈合,90%的病人能够恢复到损伤前的运动水平,无明显手术并发症,所有患者对治疗结果满意。结论 综合护理指导对带线



目的:探讨带线锚钉修复伸肌止点治疗顽固性网球肘相应护理指导的临床效果。

方法:2009年3月至2011年5月接受单个代线锚钉修复桡侧腕短伸肌(ECRB)及指总伸肌腱止点治疗的顽固性肱骨外髁炎患者10例,共10肘,采用有效术前宣教和术后分阶段的综合护理指导。

结果:本组10例患者术后切口均一期愈合,90%的病人能够恢复到损伤前的运动水平,无明显手术并发症,所有患者对治疗结果满意。结论 综合护理指导对带线锚钉修复伸肌止点治疗顽固性网球肘辅助作用明确,可明显提高手术疗效,缩短肘关节功能恢复时间,临床效果确切,值得推广。

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1632843, encodeId=f23d16328437d, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Wed Dec 17 02:06:00 CST 2014, time=2014-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699564, encodeId=403b169956489, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Jul 12 08:06:00 CST 2014, time=2014-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080715, encodeId=3e002080e1584, content=<a href='/topic/show?id=920e48565f8' target=_blank style='color:#2F92EE;'>#带线锚钉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48565, encryptionId=920e48565f8, topicName=带线锚钉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Tue Aug 05 01:06:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7204, encodeId=0a9fe204ce, content=不错研究,有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Feb 03 23:38:00 CST 2014, time=2014-02-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1632843, encodeId=f23d16328437d, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Wed Dec 17 02:06:00 CST 2014, time=2014-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699564, encodeId=403b169956489, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Jul 12 08:06:00 CST 2014, time=2014-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080715, encodeId=3e002080e1584, content=<a href='/topic/show?id=920e48565f8' target=_blank style='color:#2F92EE;'>#带线锚钉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48565, encryptionId=920e48565f8, topicName=带线锚钉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Tue Aug 05 01:06:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7204, encodeId=0a9fe204ce, content=不错研究,有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Feb 03 23:38:00 CST 2014, time=2014-02-03, status=1, ipAttribution=)]
    2014-07-12 circumcision
  3. [GetPortalCommentsPageByObjectIdResponse(id=1632843, encodeId=f23d16328437d, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Wed Dec 17 02:06:00 CST 2014, time=2014-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699564, encodeId=403b169956489, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Jul 12 08:06:00 CST 2014, time=2014-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080715, encodeId=3e002080e1584, content=<a href='/topic/show?id=920e48565f8' target=_blank style='color:#2F92EE;'>#带线锚钉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48565, encryptionId=920e48565f8, topicName=带线锚钉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Tue Aug 05 01:06:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7204, encodeId=0a9fe204ce, content=不错研究,有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Feb 03 23:38:00 CST 2014, time=2014-02-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1632843, encodeId=f23d16328437d, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Wed Dec 17 02:06:00 CST 2014, time=2014-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699564, encodeId=403b169956489, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Jul 12 08:06:00 CST 2014, time=2014-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080715, encodeId=3e002080e1584, content=<a href='/topic/show?id=920e48565f8' target=_blank style='color:#2F92EE;'>#带线锚钉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48565, encryptionId=920e48565f8, topicName=带线锚钉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Tue Aug 05 01:06:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7204, encodeId=0a9fe204ce, content=不错研究,有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Feb 03 23:38:00 CST 2014, time=2014-02-03, status=1, ipAttribution=)]
    2014-02-03 lovetcm

    不错研究,有意思

    0

相关资讯

JAMA:治疗网球肘不宜注射皮质醇

  澳大利亚昆士兰大学的Coombes等2月6日在《美国医学会杂志》[JAMA 2013,309(5):461-9]上发表的一项随机对照临床试验表明,对于肱骨外上髁炎(网球肘)患者,注射皮质类固醇和物理治疗1年后的完全恢复和显著改善率低于安慰剂治疗,并且复发率升高。 Effect of corticosteroid injection, physiotherapy, or both o

EFFORT 2012:锚定法修复网球肘获得更好疗效

2012年5月25日,在德国柏林召开的第13届EFFORT大会上,来自楠塔基特诊疗所、本研究的负责人Raymond R. Monto博士报告了锚钉法修复网球肘的临床疗效。 使用小的锚钉拉紧肘部撕裂肌腱并固定在上肢骨,这种手术尤其使严重的网球肘综合征患者获得良好转归。Monto博士说,锚钉法较非锚钉法更能获得短期和长期疗效。 网球肘是由桡侧腕短伸肌(ECRB)起始端炎症引起的一种